| Sales and revenues | 103.08M |
| Costs of goods sold | 46.9M |
| Gross profit on sales and revenue | 56.18M |
| Research and development | 31.96M |
| Selling, general and administrative | 44.2M |
| Restructuring charges | 7K |
| Settlement charge, net | |
| Impairment loss on equity investment | |
| Gain on equity investment | |
| Revaluation of contingent acquisition expense | -801K |
| (Loss) income from operations | -19.19M |
| Interest income | 40K |
| Interest expense | -28K |
| Other expense, net | -70K |
| (Loss) income before provision for (benefit from) income taxes | -19.25M |
| (Benefit from) provision for income taxes | -2.08M |
| Net (loss) income | -17.16M |
| Basic (in dollars per share) | -0.76 |
| Diluted (in dollars per share) | -0.76 |
| Basic (in shares) | 22.52M |
| Diluted (in shares) | 22.52M |